MADISON CLINTON: Open Payments
NPI 1093420408 · ROCKVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,348 in 96 payments from 21 companies in 2025. Trend: 2023 $1,431 · 2024 $2,290 · 2025 $2,348
Food & beverage: $2,274Education: $52Consulting: $22
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $383 |
| ARS Pharmaceuticals Operations, Inc. | 11 | $278 |
| Regeneron Healthcare Solutions, Inc. | 8 | $225 |
| GlaxoSmithKline, LLC. | 9 | $211 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $210 |
| Novartis Pharmaceuticals Corporation | 8 | $207 |
| Amgen Inc. | 9 | $173 |
| CSL Behring | 5 | $117 |
| Grifols USA, LLC | 4 | $114 |
| Incyte Corporation | 3 | $70 |
Products named: NEFFY, DUPIXENT, FASENRA, TEZSPIRE, AIRSUPRA, TRELEGY ELLIPTA, TAKHZYRO, NUCALA.
Industry payments across MD — which companies pay providers there.
